| | |
| Clinical data | |
|---|---|
| Drug class | Sirtuin-6 (SIRT6) inhibitor |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C13H8ClF3N8O2 |
| Molar mass | 400.71 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
JYQ-42 is a drug which acts as a sirtuin-6 (SIRT6) inhibitor. It has potential applications in cancer treatment, having been found to inhibit the migration of pancreatic cancer cells and thereby reduce tumor invasiveness. [1] [2]